Drug Shortage Report for ROFACT
Report ID | 220173 |
Drug Identification Number | 00343617 |
Brand name | ROFACT |
Common or Proper name | ROFACT |
Company Name | BAUSCH HEALTH, CANADA INC. |
Market Status | MARKETED |
Active Ingredient(s) | RIFAMPIN |
Strength(s) | 300MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | n/a |
ATC code | J04AB |
ATC description | DRUGS FOR TREATMENT OF TUBERCULOSIS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2024-03-08 |
Actual start date | |
Estimated end date | 2024-03-28 |
Actual end date | 2024-02-19 |
Shortage status | Avoided shortage |
Updated date | 2024-02-22 |
Company comments | Capacity Problem in Production |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2024-02-22 | French | Compare |
v3 | 2024-02-22 | English | Compare |
v2 | 2024-02-22 | French | Compare |
v1 | 2024-02-22 | English | Compare |
Showing 1 to 4 of 4